Deep Vein Thrombosis: Clinical Trials

5 trials for Deep Vein Thrombosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow Deep Vein Thrombosis: new trials by email Literature Review of Deep Vein Thrombosis trials Research Report on Deep Vein Thrombosis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban
Enoxaparin 40 milligram/0.4 milliliter Injectable Syringe 0.4 milliliters, Rivaroxaban 10 milligram Oral Tablet - Deep Vein Thrombosis, Venous Thromboembolism
Phase 4UnknownFlorida Orthopaedic Institute1282020-01-132020-01-18
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
Genotype-guided warfarin dosing, Non-genotype guided warfarin dosing - Atrial Fibrillation, Deep Vein Thrombosis
Phase 4UnknownChinese PLA General Hospital5002012-06-012013-10-09
Rosuvastatin for Preventing Deep Vein Thrombosis
Rosuvastatin 20mg/d for 14days, enoxaparin only - Deep Vein Thrombosis, Venous
Phase 4UnknownHallym University Medical Center1802009-10-012011-10-05
Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis
OmniWave Endovascular System - Deep Vein Thrombosis
Phase 4UnknownOmniSonics Medical Technologies, Inc.502008-03-012008-03-21
Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
low molecular weight heparin - Deep Vein Thrombosis, Cancer
Phase 4UnknownAzienda Ospedaliera Universitaria Policlinico3002005-03-012009-03-04

Narrower conditions

Venous Thrombosis (5)  ·  Atrial Fibrillation (1)  ·  Heart Valve Diseases (1)  ·  Neoplasms (1)  ·  Peripheral Vascular Diseases (1)  ·  Pulmonary Embolism (1)  ·  Thrombosis (1)  ·  Venous Thromboembolism (1)  ·  Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, Type 2 (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Embolism and Thrombosis (5)  ·  Vascular Diseases (5)  ·  Thrombosis (4)  ·  Arrhythmias, Cardiac (1)  ·  Embolism (1)  ·  Heart Diseases (1)  ·  Lung Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)  ·  Thromboembolism (1)

Interventions

Enoxaparin (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Rivaroxaban (1)  ·  Rosuvastatin Calcium (1)

Sponsors

Azienda Ospedaliera Universitaria Policlinico (1)  ·  Chinese PLA General Hospital (1)  ·  Florida Orthopaedic Institute (1)  ·  Hallym University Medical Center (1)  ·  OmniSonics Medical Technologies, Inc. (1)

Countries

China (1)  ·  Italy (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Hassan Mir, MD (1)  ·  John Aruny, MD (1)  ·  Sang-Ho Jo, MD (1)  ·  Sergio Siragusa, MD (1)  ·  Tong Yin, Dr. (1)  ·  Young-Jin Choi, MD (1)

Results publications

PMID 21684353, PMID 23629822, PMID 25267738, PMID 36399673